World's Best Scientists 2026 revealed!
Tore K. Kvien

Tore K. Kvien

Award Badge
Medicine
Norway
2026

D-Index & Metrics

Medicine

D-Index
138
Citations
111612
World Ranking
1792
National Ranking
4

Research.com Recognitions

  • 2026 - Research.com Medicine in Norway Leader Award
  • 2025 - Research.com Medicine in Norway Leader Award
  • 2023 - Research.com Medicine in Norway Leader Award
  • 2022 - Research.com Medicine in Norway Leader Award

Overview

Tore K. Kvien is affiliated with the University of Oslo in Norway and has a significant publication record primarily within the field of medicine, with a strong focus on rheumatology. Their research contributions extend to immunology, genetics, hematology, and infectious diseases. The primary research topics associated with their work include rheumatoid arthritis research and therapies, spondyloarthritis studies and treatments, autoimmune and inflammatory disorders research, systemic lupus erythematosus research, chronic lymphocytic leukemia research, biosimilars and bioanalytical methods, and osteoarthritis treatment and mechanisms.

Among the recent papers involving Tore K. Kvien or their collaborative network are:

  • Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases (2021, JAMA)
  • Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration (2022, Annals of the Rheumatic Diseases)
  • The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems (2021, Seminars in Arthritis and Rheumatism)
  • Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases (2021, JAMA)
  • The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries (2020, Lara D. Veeken)

The venues where Tore K. Kvien has frequently published include:

  • Annals of the Rheumatic Diseases
  • RMD Open
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • Osteoarthritis and Cartilage

The scientist has collaborated regularly with colleagues such as Espen A. Haavardsholm, Joseph Sexton, Sella Aarrestad Provan, Hilde Berner Hammer, and Till Uhlig, with collaboration counts ranging from 36 to 57 joint works.

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

    Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

    M J Peters;D P M Symmons;D McCarey;B A Dijkmans

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

    R. Agca;S. C. Heslinga;S. Rollefstad;M. Heslinga

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

    Josef S Smolen;Joachim R Kalden;David L Scott;Blaz Rozman

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

    Kristin K Jørgensen;Inge C Olsen;Guro L Goll;Merete Lorentzen

  • Ankylosing Spondylitis Disease Activity Score (ASDAS) : defining cut-off values for disease activity states and improvement scores

    Pedro Machado;Robert Landewé;Elisabeth Lie;Tore K Kvien

  • Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up.

    Margreth Grotle;Kare Birger Hagen;Bard Natvig;Fredrik A Dahl

  • Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.

    Glenn Haugeberg;Till Uhlig;Jan A. Falch;Johan I. Halse

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

Frequent Co-Authors

Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Laure Gossec
Laure Gossec Sorbonne University
Paul Emery
Paul Emery University of Leeds
Maxime Dougados
Maxime Dougados Hôpital Cochin
Karel Pavelka
Karel Pavelka Charles University
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Mikkel Østergaard
Mikkel Østergaard University of Copenhagen
Daniel Aletaha
Daniel Aletaha Medical University of Vienna
Robert Landewé
Robert Landewé University of Amsterdam
Cem Gabay
Cem Gabay University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers but seeking flexible study options, several online degree pathways are available. Many nurses are now choosing online rn to bsn no clinicals programs, letting working professionals advance without the need for extra clinical hours.

Advanced nursing professionals can benefit from accelerated options, such as a 1 year dnp program online. These programs enable students to complete their Doctor of Nursing Practice quickly, helping them enter leadership roles faster.

If dissertation requirements are a concern, some schools offer dnp programs without dissertation. This can make the doctorate more accessible and manageable, especially for those balancing career and academic demands.

For entry into nursing, lpn accelerated program options provide a fast-track path to becoming a licensed practical nurse, perfect for those who want to start their healthcare journey quickly.

Exploring these online degrees can open up diverse and rewarding career opportunities in medicine and nursing, providing flexible solutions for busy students.

Best Scientists Citing Tore K. Kvien

Trending Scientists

Recently Published Articles